drugs

A UK health minister has been criticised for his remarks regarding the "inevitable" drug shortages in the country.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

AAH Pharmaceuticals managing director and chairman, Mark James, said: "Health minister Simon Burns was in denial over medical shortages after he made written comments in reply to a parliamentary question by MP Margot James, saying ‘some shortages and delivery delays are inevitable’ and that the department has, ‘well established arrangements for dealing with these’."

The chairman continued: "If the Department has ‘well established arrangements’ for dealing with shortages what are these? And if they exist why are they not working? This is a worryingly complacent response which shows no understanding of the scale or seriousness of the problem. The reality is that the guidance produced by the Department of Health has had no impact whatsoever. Problems with the availability of certain medicines are as bad as ever."

Burns’ comments come as the All Party Pharmacy Group continues its inquiry into supply chain shortages, which will take further oral evidence today.

James added: "Wholesalers have put forward constructive proposals including amending regulations to reflect new Patient Service Obligations, independent third party monitoring and improved emergency supply arrangements, but we will not make progress unless the Department of Health is willing to play its part."

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

 

Caption: UK health ministers have said drug shortages are inevitable. Credit: Lori Martin

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact